RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil
Sponsor: Bill and Melinda Gates Foundation
This PHASE3 trial investigates Eclampsia and HELLP Syndrome and is currently completed. Bill and Melinda Gates Foundation leads this study, which shows 6 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE3
-
Jun 2018 — Sep 2020 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jul 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bill and Melinda Gates Foundation
- Faculdade de Medicina de Botucatu, UNESP, Botucatu, Brasil
- Feculdade de Medicina da Universidade de Sao Paulo - Brasil
- Fogarty International Center of the National Institute of Health
- Global Network for Women's and Children's Health Research
- Hospital de Clinicas de Porto Alegre
- NICHD Global Network for Women's and Children's Health
- National Cancer Institute (NCI)
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Dental and Craniofacial Research (NIDCR)
- RTI International
- Universidade Federal de Pernambuco
- University of Campinas, Brazil
- University of Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .